BlackRock Amends USANA Health Sciences Stake as of Dec 31, 2023

Ticker: USNA · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 896264

Usana Health Sciences Inc SC 13G/A Filing Summary
FieldDetail
CompanyUsana Health Sciences Inc (USNA)
Form TypeSC 13G/A
Filed DateJan 24, 2024
Risk Levellow
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investment

TL;DR

**BlackRock just updated its USANA Health Sciences stake, signaling a portfolio adjustment.**

AI Summary

BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating a change in its ownership stake in USANA Health Sciences Inc. as of December 31, 2023. This filing, an amendment number 4, updates BlackRock's passive investment position in USANA's Common Stock. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence or strategy regarding USANA, potentially influencing other investors.

Why It Matters

This filing shows BlackRock, a massive investment firm, updated its ownership in USANA Health Sciences, which can be seen as a vote of confidence or a strategic adjustment by a major player.

Risk Assessment

Risk Level: low — This is a routine update from a passive institutional investor and doesn't indicate any immediate significant risk or opportunity.

Analyst Insight

Investors should note BlackRock's continued presence as a shareholder, but this routine update doesn't necessitate immediate action. It's a data point for understanding institutional interest.

Key Players & Entities

  • BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
  • USANA Health Sciences Inc. (company) — the subject company in which BlackRock holds shares
  • December 31, 2023 (date) — the date of the event requiring this filing
  • January 24, 2024 (date) — the date the SC 13G/A was filed
  • 90328M107 (other) — the CUSIP number for USANA Health Sciences Inc. Common Stock

Forward-Looking Statements

  • BlackRock will continue to be a significant institutional holder of USANA Health Sciences Inc. common stock. (BlackRock Inc.) — high confidence, target: 2025-01-24

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 4, as stated in the filing.

Who is the filer of this SC 13G/A?

The filer of this SC 13G/A is BlackRock Inc., as indicated in the 'FILED BY' section of the filing.

What is the subject company of this filing?

The subject company is USANA HEALTH SCIENCES INC, as stated under 'SUBJECT COMPANY' and 'Name of Issuer' in the filing.

What was the date of the event that required this filing?

The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' next to '[X] Rule 13d-1(b)' in the filing.

Filing Details

This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding USANA HEALTH SCIENCES INC (USNA).

View full filing on EDGAR

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.